The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Automated And Closed Cell Therapy Processing Systems Market By The End Of 2030?

The market size for automated and closed cell therapy processing systems has experienced significant expansion in recent years. Projections indicate its value will increase from $1.53 billion in 2025 to $1.8 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 17.6%. Historically, this growth can be linked to factors such as manual cell processing methods, considerable contamination risks, restricted workflow automation, dependence on traditional bioreactors, and the gradual adoption of regenerative therapies.

The market for automated and closed cell therapy processing systems is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $3.34 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 16.7%. This anticipated growth over the forecast period is primarily driven by factors such as the creation of integrated closed-system platforms, progress in robotics and microfluidics technology, the expanding development pipelines for cell and gene therapies, stricter regulatory compliance requirements, and the proliferation of contract manufacturing organizations (cramos) for cell therapies. Key trends expected during this period involve a greater embrace of single-use and closed systems, a heightened need for automated cell therapy processes, a concentrated effort on reducing contamination risks and improving safety measures, the integration of platforms capable of handling multiple cell processing steps, and the broadening use of these systems in regenerative medicine and oncology treatments.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27214&type=smp

What Primary Drivers Are Shaping The Development Of The Automated And Closed Cell Therapy Processing Systems Market?

The expanding requirement for personalized medicine is anticipated to boost the growth of the automated and closed-cell therapy processing systems market moving forward. Personalized medicine refers to medical treatments designed specifically for an individual’s genetic, molecular, or cellular profile to optimize effectiveness and reduce adverse reactions. The increasing demand for personalized medicine stems from reinforced regulatory structures and incentives that prioritize the approval of targeted and curative therapies over broad-use drugs. Automated and closed-cell therapy processing systems facilitate personalized medicine by enabling manufacturers to create consistent, high-quality, patient-specific cell therapies that meet strict regulatory standards. For instance, in May 2025, according to the Personalized Medicine Coalition (PMC), a US-based non-profit organization, the FDA approved 18 new personalized medicines in 2024, including six gene- or cell-based therapies, representing roughly 38 percent of all new molecular entities. Therefore, the growing demand for personalized medicine is a key driver for the automated and closed-cell therapy processing systems market.

Which Segment Classifications Shape The Automated And Closed Cell Therapy Processing Systems Market?

The automated and closed cell therapy processing systems market covered in this report is segmented –

1) By Component: Software, Hardware, Consumables

2) By Technology: Microfluidics, Robotics, Bioreactors, Single-Use Technology, Three-Dimensional (3D) Cell Culture

3) By Workflow: Cryopreservation, Separation, Fill-Finish, Expansion, Apheresis, Other Workflows

4) By Application: Oncology, Regenerative Medicine, Autoimmune Diseases, Infectious Diseases, Cardiovascular Diseases

5) By End User: Pharmaceutical Companies, Biotechnology Companies, Research Institutes, Contract Manufacturing Organizations, Hospitals

Subsegments:

1) By Software: Process Control Software, Data Management Software, Quality Monitoring Software, Workflow Automation Software, Integration Software

2) By Hardware: Cell Separation Devices, Bioreactors, Fluid Handling Systems, Centrifuges, Tubing And Connectors

3) By Consumables: Sterile Bags, Culture Media, Reagents And Buffers, Filters And Cartridges, Single-Use Tubing Sets

How Are Trends Impacting The Automated And Closed Cell Therapy Processing Systems Market?

Major companies in the automated and closed cell therapy processing systems market are concentrating on developing advanced solutions, such as cell preparation platforms, to minimize manual labor and the risk of contamination during cell processing. These cell preparation platforms are automated systems designed for the efficient isolation, processing, and preparation of cells for subsequent analysis or clinical application. For instance, in October 2024, Sino-Biocan Biotechnology Ltd., a China-based biotech company, introduced the WUKONG Automated, Closed, Integrated Cell Processing System, which signifies a significant advancement in cell therapy manufacturing. This system provides a fully automated, closed platform that streamlines processes from initial blood collection to cell culture and final filling. It is engineered to benefit hospitals, pharmaceutical research and development teams, and contract development and manufacturing organizations by enhancing efficiency, reducing contamination risks, and ensuring good manufacturing practice-grade consistency through intelligent controls and real-time monitoring.

Which Companies Are Expanding Their Footprint In The Automated And Closed Cell Therapy Processing Systems Market?

Major companies operating in the automated and closed cell therapy processing systems market are Thermo Fisher Scientific Inc., Fresenius SE & Co. KGaA, Danaher Corporation, Merck KGaA, Parker Hannifin Corp., Corning Incorporated, Kawasaki Heavy Industries Ltd., Dover Corporation, Lonza Group AG, Terumo Corporation, Sartorius AG, Charles River Laboratories International Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Hamilton Company, Repligen Corporation, Cellares Inc., Ori Biotech Ltd., Autolus Therapeutics Plc.

Read the full automated and closed cell therapy processing systems market report here:

https://www.thebusinessresearchcompany.com/report/automated-and-closed-cell-therapy-processing-systems-global-market-report

How Does The Automated And Closed Cell Therapy Processing Systems Market Perform Across Major Global Regions?

North America was the largest region in the automated and closed cell therapy processing systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated and closed cell therapy processing systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Automated And Closed Cell Therapy Processing Systems Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27214&type=smp

Browse Through More Reports Similar to the Global Automated And Closed Cell Therapy Processing Systems Market 2026, By The Business Research Company

People Counting System Market Report 2026

https://www.thebusinessresearchcompany.com/report/people-counting-system-global-market-report

Sorting Machines Market Report 2026

https://www.thebusinessresearchcompany.com/report/sorting-machines-global-market-report

Slot Machines Market Report 2026

https://www.thebusinessresearchcompany.com/report/slot-machines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model